Skip to main content

News

By Jeff Lagasse | 11:48 am | January 23, 2023
Challenges could result from the timing of their prescription fills and their income, the report finds.
By Jeff Lagasse | 03:50 pm | January 20, 2023
In addition to exceeding its financial forecast, a national search will seek to replace its longtime CEO, who is retiring this year.
By Susan Morse | 03:38 pm | January 20, 2023
Focus on what you can control, say Alvarez and Marsal Managing Directors Peter Urbanowicz and Martin McGahan.
By Jeff Lagasse | 12:31 pm | January 20, 2023
The group says the program has devolved into a "cumbersome process" involving lengthy approvals and insurer negotiations.
By Jeff Lagasse | 11:55 am | January 20, 2023
The AG's office accused drugmakers of "unlawful, unfair, and deceptive business practices."
By Susan Morse | 11:07 am | January 20, 2023
"We have seen a $400 per member, per month improvement in patient total cost of care," says CMO Jonathan Welch. 
By Jeff Lagasse | 04:23 pm | January 19, 2023
Adverse drug events comprise 39% of the adverse events, making them the most common by far.
By Jeff Lagasse | 12:05 pm | January 19, 2023
Nearly all states indicated using at least one specified strategy to increase the behavioral health workforce.
By Susan Morse | 11:04 am | January 19, 2023
The change reportedly includes executive job cuts.
By Jeff Lagasse | 07:08 pm | January 18, 2023
The action furthers a larger goal of improving the accuracy of the quality information that is publicly reported in the Five-Star Rating System.